Chen, YunYunChenTsai, Huang-WenHuang-WenTsaiTsai, Ya-HuiYa-HuiTsaiSHENG-HONG TSENG2021-12-242021-12-242021-0800223468https://scholars.lib.ntu.edu.tw/handle/123456789/590664The phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway is closely related to oncogenesis. PI3K/mTOR inhibitors are considered capable of counteracting the feedback mechanisms within the pathway. In this study, we investigated the antitumor effects of VS-5584, an orally administered PI3K/mTOR dual inhibitor, on neuroblastomas.enAntitumor effects; Neuroblastoma; PI3K/mTOR dual inhibitor; VS-5584journal article10.1016/j.jpedsurg.2020.10.033331892972-s2.0-85096057460https://scholars.lib.ntu.edu.tw/handle/123456789/561035